Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Vasectomy and Risk of Prostate Cancer in a Screening Trial. 28830873 Shoag J, Savenkov O, Christos PJ, Mittal S, Halpern JA, Askin G, Shoag D, Golan R, Lee DJ, O'Malley P, Najari B, Eisner B, Hu JC, Scherr D, Schlegel P, Barbieri CE Cancer Epidemiol. Biomarkers Prev. 2017 PLCO
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. 28869989 Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R Ann. Intern. Med. 2017 PLCO
Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality? 28976536 Doroudi M, Schoen RE, Pinsky PF Cancer 2017 PLCO
Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer. 29061540 Halpern JA, Oromendia C, Shoag JE, Mittal S, Cosiano MF, Ballman KV, Vickers AJ, Hu JC J. Urol. 2017 PLCO
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival. 29156299 Temkin SM, Miller EA, Samimi G, Berg CD, Pinsky P, Minasian L Eur. J. Cancer 2017 PLCO
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials. 29211316 de Koning HJ, Gulati R, Moss SM, Hugosson J, Pinsky PF, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, de Carvalho TM, Feuer EJ, Tsodikov A, Mariotto AB, Heijnsdijk EAM, Etzioni R Cancer 2017 PLCO
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies. 28196067 Petrick JL, Kelly SP, Liao LM, Freedman ND, Graubard BI, Cook MB Br. J. Cancer 2017 PLCO
Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. 28087510 Holme Ø, Schoen RE, Senore C, Segnan N, Hoff G, Løberg M, Bretthauer M, Adami HO, Kalager M BMJ 2017 PLCO
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. 28376113 Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R PLoS Med. 2017 NLST, PLCO
The association between Dietary Inflammatory Index scores and the prevalence of colorectal adenoma. 28345504 Haslam A, Wagner Robb S, Hébert JR, Huang H, Wirth MD, Shivappa N, Ebell MH Public Health Nutr 2017 PLCO
Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men. 28369777 Layne TM, Weinstein SJ, Graubard BI, Ma X, Mayne ST, Albanes D Cancer 2017 PLCO
A Novel Approach for Pathway Analysis of GWAS Data Highlights Role of BMP Signaling and Muscle Cell Differentiation in Colorectal Cancer Susceptibility - Erratum. 28228184 Mishra A, MacGregor S Twin Res Hum Genet 2017 PLCO
On estimation of time-dependent attributable fraction from population-based case-control studies. 28099992 Zhao W, Chen YQ, Hsu L Biometrics 2017 PLCO
Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. 28139693 Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melan… Nat Commun 2017 PLCO
Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. 29117387 Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, John EM, Park JY, Xu J, Stevens VL, Berndt SI, Huff CD, Wang Z, Yeboah ED, Tettey Y, B… J. Natl. Cancer Inst. 2017 PLCO
TET2 binds the androgen receptor and loss is associated with prostate cancer. 27819678 Nickerson ML, Das S, Im KM, Turan S, Berndt SI, Li H, Lou H, Brodie SA, Billaud JN, Zhang T, Bouk AJ, Butcher D, Wang Z, Sun L, Misner K, Tan W, Esnakula A, Esposito D, Huang WY, Hoover RN, Tucker MA, Keller JR, Boland J, Brown K, Anderson SK, Moore… Oncogene 2017 PLCO
Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer. 28359301 Zuber V, Bettella F, Witoelar A, PRACTICAL Consortium, CRUK GWAS, BCAC Consortium, TRICL Consortium, Andreassen OA, Mills IG, Urbanucci A BMC Genomics 2017 PLCO
Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. 27741566 Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Blot W, T… Int. J. Cancer 2017 PLCO
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. 29089348 Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K, Martin RM, Lewis SJ, Gunter MJ, Mondul A, Shui IM, Theodoratou E, Nimptsch K, Lindström S, Albanes D, Kühn T, Key TJ, Travis RC, Vimaleswaran KS, GECCO Consortium, PRACTICAL Consor… BMJ 2017 PLCO
SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns. 28039167 Lin HY, Chen DT, Huang PY, Liu YH, Ochoa A, Zabaleta J, Mercante DE, Fang Z, Sellers TA, Pow-Sang JM, Cheng CH, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestga… Bioinformatics 2017 PLCO